OxLDLs participate in numerous metabolic processes leading to the development of atherosclerosis (Figure 5), including enhancing the expression of adhesion molecules such as ICAM-1 (intracellular adhesion molecule-1) or VCAM-1 (vascular cell adhesion molecule-1) for monocytes on the endothelial surface, and chemotaxis by increasing the expression of MCP1 (macrophage chemotactic protein 1) [24]. This evidence concerns the gene VCAM1 and atherosclerosis.